RAPT Therapeutics (RAPT) Share-based Compensation (2020 - 2024)
Historic Share-based Compensation for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $4.6 million.
- Therapeutics' Share-based Compensation rose 361.26% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.9 million, marking a year-over-year increase of 1664.03%. This contributed to the annual value of $19.9 million for FY2024, which is 1664.03% up from last year.
- Latest data reveals that Therapeutics reported Share-based Compensation of $4.6 million as of Q4 2024, which was up 361.26% from $4.6 million recorded in Q3 2024.
- Therapeutics' 5-year Share-based Compensation high stood at $5.4 million for Q1 2024, and its period low was $2.0 million during Q3 2020.
- For the 5-year period, Therapeutics' Share-based Compensation averaged around $3.3 million, with its median value being $2.9 million (2021).
- Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 1845.19% in 2021, then skyrocketed by 5864.52% in 2023.
- Quarter analysis of 5 years shows Therapeutics' Share-based Compensation stood at $2.6 million in 2020, then decreased by 18.45% to $2.1 million in 2021, then surged by 45.01% to $3.0 million in 2022, then skyrocketed by 46.41% to $4.4 million in 2023, then rose by 3.61% to $4.6 million in 2024.
- Its last three reported values are $4.6 million in Q4 2024, $4.6 million for Q3 2024, and $5.4 million during Q2 2024.